Grace Therapeutics
NASDAQ: GRCEPrinceton, US · Delaware corporation
Grace Therapeutics is a biopharmaceutical company developing therapies for aneurysmal subarachnoid hemorrhage (aSAH), a condition with high mortality and morbidity that affects a relatively young patient population. The company is publicly traded and provides investor updates on its drug development pipeline.
Founders & leadership
RJ
Robert J. DelAversanoExecutive
AK
Amresh KumarVP of Program Management
PK
Prashant KohliChief Executive Officer
CD
Carrie D'AndreaVP Clinical Operations
DR
Dr. R. Loch MacdonaldChief Medical Officer
JD
Janelle D'AlviseExecutive
VK
Vimal KavuruNamed on SEC filing
J(
Jean-Marie (John) CananNamed on SEC filing
LP
Linda P. O'KeefeNamed on SEC filing
DO
Donald OldsNamed on SEC filing
RN
Roderick N. CarterNamed on SEC filing
Board
SG
S. George KottayilBoard director
Reported raises · per SEC filings
Form D private placements$32.9M disclosed across 4 rounds · 2018–2026
▶$10MraisedAug 2026 · 9 investors · PharmaceuticalsRule 506(b)
▶$10MraisedAug 2026 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Prashant KohliExecutive Officer, Director
- Vimal KavuruDirector
- Robert J. DelAversanoExecutive Officer
- A. Brian DavisDirector
- S. George KottayilDirector
- Edward NeugeborenDirector
- Dr. R. Loch MacdonaldExecutive Officer
- Amresh KumarExecutive Officer
- Offering amount
- $10M
- Amount sold
- $10M
- Minimum investment
- $1
- Sales commissions
- $560K
- Placement agents
- Craig-Hallum Capital Group
- First sale
- Aug 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MraisedFeb 2025 · 14 investors · BiotechnologyRule 506(b)
▶$15MraisedFeb 2025 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert J. DelAversanoExecutive Officer
- Amresh KumarExecutive Officer
- Prashant KohliDirector, Executive Officer
- Carrie D'AndreaExecutive Officer
- S. George KottayilDirector
- Edward NeugeborenDirector
- A. Brian DavisDirector
- Dr. R. Loch MacdonaldExecutive Officer
- Vimal KavuruDirector
- Offering amount
- $30M
- Amount sold
- $15M
- Minimum investment
- $1
- Sales commissions
- $1.5M
- Placement agents
- TD Securities (USA) LLC
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.5MraisedOct 2023 · 4 investors · BiotechnologyRule 506(b)
▶$7.5MraisedOct 2023 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Donald OldsDirector
- Michael DerbyDirector
- Prashant KohliExecutive Officer
- Vimal KavuruDirector
- Amresh KumarExecutive Officer
- Brian FordExecutive Officer
- Carrie D'AndreaExecutive Officer
- Dr. R. Loch MacdonaldExecutive Officer
- Offering amount
- $15.1M
- Amount sold
- $7.5M
- First sale
- Sep 2023
- Incorporated
- Corporation, Quebec, Canada
- Federal exemptions
- 06b
▶$372.6KraisedMay 2018 · 1 investors · BiotechnologyRule 506(b)
▶$372.6KraisedMay 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jean-Marie (John) CananDirector
- Linda P. O'KeefeExecutive Officer
- Donald OldsDirector
- Roderick N. CarterDirector
- Janelle D'AlviseExecutive Officer, Director
- Offering amount
- $837.5K
- Amount sold
- $372.6K
- Sales commissions
- $26.1K
- Placement agents
- Mackie Research Capital Corporation
- First sale
- May 2018
- Incorporated
- Corporation, Quebec, Canada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Robinhood17 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Perplexity13 shared keywordsAn AI-powered answer engine providing accurate, trusted, and real-time answers to questions.
Public12 shared keywordsPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.
TipRanks12 shared keywordsFinancial analysis and stock research platform.
Companies competing with Grace Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Grace Therapeutics registers 4.8M-share resale | GRCE S-3 Registrationstocktitan.net · Aug 2026Frequently asked questions
- What does Grace Therapeutics do?
- Grace Therapeutics is a biopharmaceutical company developing therapies for aneurysmal subarachnoid hemorrhage (aSAH), a condition with high mortality and morbidity that affects a relatively young patient population. The company is publicly traded and provides investor updates on its drug development pipeline.
- How much funding has Grace Therapeutics raised?
- Grace Therapeutics has disclosed $32.9M raised across 4 rounds.
- Where is Grace Therapeutics headquartered?
- Grace Therapeutics is headquartered in Princeton, US.